Monday, October 18, 2021

GSK - NEW PHASE 3 DATA FOR DAPRODUSTAT ON POTENTIAL TREATMENT FOR ANAEMIA

 GSK - NEW PHASE 3 DATA FOR DAPRODUSTAT ON POTENTIAL TREATMENT FOR PATIENTS WITH ANAEMIA DUE TO CHRONIC KIDNEY DISEASE IN DIALYSIS, NON-DIALYSIS PEOPLE

https://www.marketscreener.com/news/latest/GSK-NEW-PHASE-3-DATA-FOR-DAPRODUSTAT-ON-POTENTIAL-TREATMENT-FOR-PATIENTS-WITH-ANAEMIA-DUE-TO-CHRON--36710477/

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.